TP53 and chronic myelogenous leukemia, BCR-ABL1 positive: Exposure of hepatocarcinoma cells to 4-MU resulted in upregulation of p5379 and treatment of human chronic myelogenous leukemia cells, K562, with 4-MU was found to affect apoptosis by increasing p53 expression80.